Q4 2025 Chemed Corp Earnings Call Transcript
Key Points
- VITAS Healthcare saw a 6% improvement in admissions compared to the same period in 2024, indicating growth in patient intake.
- The Florida Medicare Cap position improved by almost $25 million, suggesting effective management of billing limitations.
- Chemed Corp (CHE) received a certificate of need to operate in Manatee County, Florida, presenting new growth opportunities.
- Roto-Rooter branches with commercial business managers experienced a 10% higher revenue increase compared to those without.
- Chemed Corp (CHE) repurchased 400,000 shares, demonstrating confidence in the company's value and returning capital to shareholders.
- The fourth quarter of 2025 fell short of expectations for both VITAS and Roto-Rooter, impacting overall financial performance.
- Roto-Rooter revenue declined by 3.7% in the fourth quarter compared to the same period in 2024, indicating challenges in maintaining growth.
- Implicit price concessions and credit memos at Roto-Rooter increased by $4 million or 57%, reflecting issues in billing and collections.
- Adjusted EBITDA margin for Roto-Rooter decreased by 477 basis points compared to the fourth quarter of 2024, due to higher marketing costs and write-offs.
- Chemed Corp (CHE) anticipates a transition year in 2026, with improvements expected mainly in the second half, indicating ongoing operational challenges.
Good day, and thank you for standing by. Welcome to the Chemed Corporation fourth quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Holley Schmidt, Assistant Controller. Please go ahead.
Good morning. Our conference call this morning will review the financial results for the fourth quarter of 2025 ended December 31, 2025. Before we begin, let me remind you of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 apply to this conference call.
During the course of this call, the company will make various remarks concerning management's expectations, predictions, plans, and prospects that constitute forward-looking statements. Actual results may differ materially from these -- from those projected by these forward-looking statements as a result of a variety of factors, including those identified in the company's news
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
